Treatment with resveratrol (a SIRT1 activator) protects mice against diet-induced obesity and insulin resistance [49] (although SIRT1 is not the only target of resveratrol, and has not been shown to be the critical functional target of the drug in these studies). Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.